PT - JOURNAL ARTICLE AU - Jagtap, Dhanashree AU - Bhor, Vikrant M AU - Bhowmick, Shilpa AU - Kasarpalkar, Nandini AU - Sagvekar, Pooja AU - Kulkarni, Bhalchandra AU - Pathak, Manish AU - Chatterjee, Nirjhar AU - Dolas, Pranam AU - Palav, Harsha AU - Kaginkar, Snehal AU - Bhagat, Sharad AU - Munshi, Itti AU - Parikh, Swapneil AU - Agrawal, Sachee AU - Pawar, Chandrakant AU - Kaneria, Mala AU - Mahale, Smita D AU - Shastri, Jayanthi AU - Patel, Vainav TI - sMAdCAM:IL-6 ratio influences disease progression and anti-viral responses in SARS-CoV-2 infection AID - 10.1101/2020.10.13.20182949 DP - 2021 Jan 01 TA - medRxiv PG - 2020.10.13.20182949 4099 - http://medrxiv.org/content/early/2021/03/16/2020.10.13.20182949.short 4100 - http://medrxiv.org/content/early/2021/03/16/2020.10.13.20182949.full AB - Recent studies positing the gut as a sanctuary site for viral persistence in SARS-CoV-2 infection highlight the importance of assimilating profiles of systemic as well as gut inflammatory mediators to understand the pathology of COVID-19. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n=84) of SARS-C0V-2 infected individuals included a group of in-patients (n=60) at various stages of disease progression together with convalescent individuals (n=24) recruited between April and June 2020 from Mumbai, India. Follow-up of 35 in-patients at day 7 post diagnosis was carried out. Th1/Th2/Th17 cytokines along with soluble MAdCAM (sMAdCAM) levels in plasma were measured. Also, anti-viral humoral response as measured by rapid antibody test (IgG, IgM), Chemiluminescent Immunoassay (IgG) and antibodies binding to SARS-CoV-2 proteins were measured by Surface Plasmon Resonance (SPR) from plasma.IL-6 and sMAdCAM levels among in-patients inversely correlated with one another. When expressed as a novel integrated marker –sMIL index (sMAdCAM/IL-6 ratio), these levels were incrementally and significantly higher in various disease states with convalescents exhibiting the highest values. Importantly, sMAdCAM levels as well as sMIL index (fold change) correlated with peak association rates of receptor binding domain and fold change in binding to spike respectively as measured by SPR. Our results highlight key systemic and gutassociated parameters that need to be monitored and investigated further to optimally guide therapeutic and prophylactic interventions for COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementICMR-NIRRH Intramural Core SupportAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:KASTURBA HOSPITAL FOR INFECTIOUS DISEASES Institutional Review Board, Approval dated April 17,2020. ICMR-NIRRH Ethics Committee for Clinical Studies, Approval dated April 16, 2020; project no. 399/2020All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available for review upon request to corresponding authors.